Despite concerns over the safety of anti-Covid drug molnupiravir, Indians have purchased around 1.2 crore pills worth Rs 50 crore within the first month of its launch, data shows.Despite concerns over the safety of anti-Covid drug molnupiravir, India
Antibiotic medicine Azithral became the largest-selling pharma brand in January 2022 for the first time ever, overtaking the market leader anti-diabetic therapy - Human Mixtard, according to report.Antibiotic medicine Azithral became the largest-sell
JB Chemicals & Pharmaceuticals Limited (JB), one of the fastest growing pharmaceutical companies in India, announced its financial results for the third quarter ended December 31, 2021.JB Chemicals & Pharmaceuticals Limited (JB), one of the fastest g
Molnupiravir, the first oral antiviral for treatment of mild to moderate Covid approved by the US Food and Drug Administration (FDA), seems to have bombed in the domestic market. This is far different than the first two waves when Covid therapies had
Recently, pharmaceutical company Abbott said it has tied up with various health tech firms like BeatO, Sugar.fit, PharmaEasy, GOQii, 1MG and Zyla for diabetes care.
Gennova Biopharmaceuticals, a subsidiary of Pune-based drugmaker Emcure Pharmaceuticals, is developing a Covid-19 vaccine on its mRNA platform which will target the Omicron variant, the strain that is driving the third coronavirus infection wave in t
Hyderabad-based Biological E has sought extension of shelf life of its Covid-19 vaccine Corbevax by up to 12 months from India's drug regulatory authority.Hyderabad-based Biological E has sought extension of shelf life of its Covid-19 vaccine Corbeva
Tata Medical and Diagnostics on Tuesday said its OmiSure RT-PCR test has been upgraded to detect the new BA.2 sub-lineages of Omicron. In an evaluation carried out by ICMR and the Virus Research & Diagnostics Laboratory, Kasturba Hospital for Infecti
The Drugs Controller General of India (DCGI) has approved Serum Institute of India's proposal to manufacture a vaccine against omicron variant of coronavirus for examination, test and analysis, official sources said. The Drugs Controller General of I
Recently, the board of directors of Panacea Biotec Pharma Limited has approved the sale of its domestic business assets, which include its pharmaceutical formulations brands in India and Nepal
, CDSCO.jpg)
